Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2025-12-26 @ 3:44 AM
NCT ID:
NCT02663518
Group ID:
EG006
Title:
Part 2: Ontorpacept (PF-07901800/TTI-621) + Rituximab Combination
Description:
Participants with CD20-positive malignancies received 0.1 mg/kg/week TTI-621 infusion along with 375 mg/m\^2 rituximab given weekly (1 cycle) for up to 8 cycles according to the institutional standard of care. Participants received TTI-621 monotherapy upon completion of combination partner regimen/unacceptable toxicity to the combination regimen.
Deaths Number Affected:
27
Deaths Number At Risk:
None
Serious Number Affected:
13
Serious Number At Risk:
40
Other Number Affected:
34
Other Number At Risk:
40
Study:
NCT02663518
Results Section:
NCT02663518
Adverse Events Module:
NCT02663518